2012-10-10 01:24:26 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "PharmaNeuroBoost NV - Product Pipeline Review - 2012" provides data on the PharmaNeuroBoost NV's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, PharmaNeuroBoost NV's corporate website, SEC filings, investor presentations and featured press releases, both from PharmaNeuroBoost NV and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* PharmaNeuroBoost NV - Brief PharmaNeuroBoost NV overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of PharmaNeuroBoost NV human therapeutic division.

* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of PharmaNeuroBoost NV with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the PharmaNeuroBoost NV's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468670_pharmaneuroboost_nv_product_pipeline_ ..


Reasons to buy

* Evaluate PharmaNeuroBoost NV's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of PharmaNeuroBoost NV in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the PharmaNeuroBoost NV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with PharmaNeuroBoost NV.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of PharmaNeuroBoost NV and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
PharmaNeuroBoost NV Snapshot
PharmaNeuroBoost NV Overview
Key Information
Key Facts
PharmaNeuroBoost NV - Research and Development Overview
Key Therapeutic Areas
PharmaNeuroBoost NV - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
PharmaNeuroBoost NV - Pipeline Products Glance
PharmaNeuroBoost NV - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
PharmaNeuroBoost NV Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
PharmaNeuroBoost NV - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
PharmaNeuroBoost NV - Drug Profiles
PNB-03
Product Description
Mechanism of Action
R&D Progress
PNB-04
Product Description
Mechanism of Action
R&D Progress
PNB-05
Product Description
Mechanism of Action
R&D Progress
PNB01
Product Description
Mechanism of Action
R&D Progress
PNB02
Product Description
Mechanism of Action
R&D Progress
PharmaNeuroBoost NV - Pipeline Products by Route of Administration
PharmaNeuroBoost NV - Pipeline Products By Mechanism of Action
PharmaNeuroBoost NV - Recent Pipeline Updates
PharmaNeuroBoost NV - Locations And Subsidiaries
Head Office
PharmaNeuroBoost NV, Recent Developments
PharmaNeuroBoost NV- Press Release
Apr 03, 2012: PharmaNeuroBoost Initiates Proof-of-Concept Study In Schizophrenia With PNB02
Dec 22, 2009: PharmaNeuroBoost N.V. Announces The Approval Of PNB01 By The Ethics Committee
Financial Deals Landscape
PharmaNeuroBoost NV, Deals Summary
PharmaNeuroBoost NV, Pharmaceuticals & Healthcare, Deal Details
Private Equity
PharmaNeuroBoost Secures $9 Million In Equity Funding
PharmaNeuroBoost Secures $2 Million In Equity Funding
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
PharmaNeuroBoost NV, Key Information
PharmaNeuroBoost NV, Key Facts
PharmaNeuroBoost NV - Pipeline by Indication, 2012
PharmaNeuroBoost NV - Pipeline by Stage of Development, 2012
PharmaNeuroBoost NV - Monotherapy Products in Pipeline, 2012
PharmaNeuroBoost NV - Phase III, 2012
PharmaNeuroBoost NV - Phase I, 2012
PharmaNeuroBoost NV - Pre-Clinical, 2012
PharmaNeuroBoost NV - Pipeline By Route of Administration, 2012
PharmaNeuroBoost NV - Pipeline Products By Mechanism of Action, 2012
PharmaNeuroBoost NV - Recent Pipeline Updates, 2012
PharmaNeuroBoost NV, Deals Summary
PharmaNeuroBoost Secures $9 Million In Equity Funding
PharmaNeuroBoost Secures $2 Million In Equity Funding

List of Figures
PharmaNeuroBoost NV - Pipeline by Indication, 2012
PharmaNeuroBoost NV - Pipeline by Stage of Development, 2012
PharmaNeuroBoost NV - Monotherapy Products in Pipeline, 2012
PharmaNeuroBoost NV - Pipeline Products By Mechanism of Action, 2012

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.